Scholar wins Early Career Research Award

  • March 30, 2016
Scholar wins Early Career Research Award

Edward Chouchani recognised by the Biochemical Society for his exceptional work.

The Biochemical Society's Awards allow the excellent work of high calibre scientists at all stages of their careers to be recognised and rewarded. The 2017 Award lecture series will showcase the outstanding contributions to molecular bioscience that the winners have made during their careers.

Professor Anne Dell

A Gates Cambridge Scholar has been awarded the prestigious Early Career Research Award for Energy and Metabolism by the Biochemical Society in recognition of his exceptional work as a molecular bioscientist.

Edward Chouchani [2008], who did his PhD in Biological Science at the University of Cambridge as a Gates Cambridge Scholar, won the £1,000 prize against a very competitive field of candidates. He is among 11 eminent biochemists and exceptional early career researchers to be recognised by the Society's 2017 Awards.

Edward will give a Medal Lecture at a Biochemical Society conference during 2017 and has also been invited to submit an article related to the Lecture to a Society-owned publication.

The Awards recognise molecular bioscientists for the excellence and profound impact their work has had and also allow exceptional work by early career researchers to be highlighted.

Professor Anne Dell, Chair of the Awards Committee, said: “The Biochemical Society's Awards allow the excellent work of high calibre scientists at all stages of their careers to be recognised and rewarded. The 2017 Award lecture series will showcase the outstanding contributions to molecular bioscience that the winners have made during their careers.”

The Early Career Research Award for Energy and Metabolism recognises the impact of research carried out by early career scientists who have no more than six years postdoctoral research experience. The Society states: "It is expected that successful candidates will have produced international quality research outputs, and be able to demonstrate ambitions and aspirations consistent with the potential to achieve world-leading status."

Edward's PhD, supervised by Dr Mike Murphy, focused on unraveling mechanisms of, and targeting therapies against, the bioenergetic dysfunction that drives ischaemia-reperfusion (IR) injury in heart attacks. He developed novel in vivo biochemical and proteomic methods to provide several significant contributions to this field. Most importantly, he established the mechanistic basis for cardioprotection by nitric oxide within mitochondria and developed a long sought-after targeted therapy for treatment of acute heart attacks.  In the course of this work, Edward was lead author on articles published in Nature and Nature Medicine, which identified new chemicals that could protect vital organs from long-term damage following a heart attack or stroke.

Edward is currently a postdoctoral fellow at the Bruce Spiegelman Lab at the Dana-Farber Cancer Institute at Harvard Medical School where he has extended the tools he developed in Cambridge to understand how mitochondria can determine healthy function of adipose tissue in mice.  This work has uncovered new mechanisms that define the anti-obesity and anti-diabetic actions of thermogenic adipose tissue.

He said: "I am very honoured to receive this award, and grateful to my colleagues and mentors for their continuing support.  I’m particularly thankful to my PhD and post-doctoral supervisors Mike Murphy and Bruce Spiegelmen for their mentorship.”    

Edward Chouchani

Edward Chouchani

  • Alumni
  • Canada
  • 2008 PhD Biological Science
  • King's College

During my undergraduate work I have been involved in extra-curricular independent research with Mobilab Technologies, a biotech company founded by a partner and myself. As its V-P I have been responsible in large part for the development of a bioelectric solar cell, offering a much lower cost alternative to conventional solar technologies by using robust, renewable biological materials. Within the academic sphere I have researched towards the improved characterization of the Stearoyl-CoA desaturase enzyme, responsible for regulation of fat storage and widely pursued potential drug target. At Cambridge I intend to develop and characterize targeted antioxidant small molecules to provide improved therapies for age-related dysfunction, as well as to further understand the role of oxidative stress in the aging process. I believe this research provides an excellent balance of entrepreneurial potential with a desire for better understanding of fundamental biochemical processes.

Latest News

Public engagement through children’s stories

An award-winning science communicator and tv presenter who honed his communication skills as a Gates Cambridge Scholar is launching a colourful children’s book about gravity. Dr Niraj Lal’s new children’s book, Henry the Flying Emu, is being launched by well-known science journalist broadcaster Robyn Williams AO, host of the ABC Science Show. The book tells the story […]

Affecting change for the Māori community

Self-determination lies at the centre of Māori culture. “It’s a way of life,” says Chris Tooley. That idea is also at the heart of his PhD studies at Cambridge and his subsequent work in Parliament and in the community. Chris grew up with a strong sense of being part of the Māori community. He has ancestral […]

On the COVID frontline

Three Gates Cambridge scholars who have been on the medical frontline during the COVID-19 pandemic will be speaking about their experiences at a virtual event next weekend. The event, organised by the Gates Cambridge Alumni Association, will be moderated by Elizabeth Dzeng, Assistant Professor of Medicine at the University of California, San Francisco in the […]

New game tackles Covid conspiracies

A new online game that puts players in the shoes of a purveyor of fake pandemic news is the latest tactic in the UK Government’s efforts to tackle the deluge of coronavirus misinformation that is misleading many and costing lives across the world. Launched to the public today, the Go Viral! game has been developed by the […]